In diseases characterized by excessive FGF23 secretion such as X-linked hypophosphatemia or chronic kidney disease, enhanced FGF23 signaling suppresses 1,25(OH)2D production in the kidney [90]. The gene discussed is FGF23; the disease is chronic kidney disease.